Scher HI - Search Results

1

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K, Halabi S, Nelson PS, Sartor O, Smith MR, Soule HR, Akaza H, Beer TM, Beltran H, Chinnaiyan AM, Daugaard G, Davis ID, De Santis M, Drake CG, Eeles RA, Fanti S, Gleave ME, Heidenreich A, Hussain M, James ND, Lecouvet FE, Logothetis CJ, Mastris K, Nilsson S, Oh WK, Olmos D, Padhani AR, Parker C, Rubin MA, Schalken JA, Scher HI, Sella A, Shore ND, Small EJ, Sternberg CN, Suzuki H, Sweeney CJ, Tannock IF, Tombal B. Gillessen S, et al. Among authors: scher hi. Ann Oncol. 2015 Aug;26(8):1589-604. doi: 10.1093/annonc/mdv257. Epub 2015 Jun 3. Ann Oncol. 2015. PMID: 26041764 Free PMC article.

2

Prostatic cancer: where do we go from here?

Scher H. Scher H. Curr Opin Oncol. 1991 Jun;3(3):568-74. Curr Opin Oncol. 1991. PMID: 1892925 Review.

3

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.

Seidman AD, Scher HI, Heinemann MH, Bajorin DF, Sternberg CN, Dershaw DD, Silverberg M, Bosl GJ. Seidman AD, et al. Among authors: scher hi. Cancer. 1991 Dec 15;68(12):2561-5. doi: 10.1002/1097-0142(19911215)68:12<2561::aid-cncr2820681205>3.0.co;2-g. Cancer. 1991. PMID: 1933802 Clinical Trial.

4

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.

Geller NL, Sternberg CN, Penenberg D, Scher H, Yagoda A. Geller NL, et al. Cancer. 1991 Mar 15;67(6):1525-31. doi: 10.1002/1097-0142(19910315)67:6<1525::aid-cncr2820670611>3.0.co;2-8. Cancer. 1991. PMID: 2001540

5

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma.

Motzer R, Scher H, Bajorin D, Sternberg C, Bosl GJ. Motzer R, et al. Invest New Drugs. 1990 Nov;8(4):391-2. doi: 10.1007/BF00198598. Invest New Drugs. 1990. PMID: 2084073 Clinical Trial.

6

Predicting biologic potential in prostate cancer.

Scher HI. Scher HI. Curr Opin Oncol. 1990 Jun;2(3):520-8. Curr Opin Oncol. 1990. PMID: 2092769 Review. No abstract available.

7

M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.

Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, Sogani P, Watson R, Darshaw D, Reuter V, et al. Scher H, et al. Prog Clin Biol Res. 1990;353:179-86. Prog Clin Biol Res. 1990. PMID: 2217417 No abstract available.

8

Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.

Gabrilove JL, Jakubowski A, Fain K, Grous J, Scher H, Sternberg C, Yagoda A, Clarkson B, Bonilla MA, Oettgen HF, et al. Gabrilove JL, et al. J Clin Invest. 1988 Oct;82(4):1454-61. doi: 10.1172/JCI113751. J Clin Invest. 1988. PMID: 2459163 Free PMC article.

9

Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.

Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B, et al. Gabrilove JL, et al. Behring Inst Mitt. 1988 Aug;(83):229-33. Behring Inst Mitt. 1988. PMID: 2467654 No abstract available.

10

Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.

Sternberg CN, Yagoda A, Scher H, Bosl G, Dershaw D, Rosado K, Houston C, Rosenbluth R, Vinciguerra V, Boselli B. Sternberg CN, et al. Eur J Cancer Clin Oncol. 1989 Apr;25(4):753-4. doi: 10.1016/0277-5379(89)90215-0. Eur J Cancer Clin Oncol. 1989. PMID: 2523810 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters